FDA Recalls Zinc Chloride Injectable Due to Sterility Concerns
Olympia Compounding Pharmacy is recalling 1,291 vials of Zinc Chloride injectable nationwide due to lack of assurance of sterility.
What this means for you
Real risk of harm even if no illness or injury has been reported yet. Stop using the product and follow the agency's guidance.
Our severity reasoning: This FDA Class II drug recall involves lack of sterility assurance in an injectable medication. The recall notice does not report any illnesses or injuries. Per the rubric, risk-of-harm products where injury has not been reported score 3 (High).
Plain-English summary
Olympia Compounding Pharmacy is recalling 1,291 vials of Zinc Chloride (0.5 mg/mL) multi-dose injectable, NDC 73198-0071-30, Lot K24024, with expiration date 5/24/2022. This is a prescription-only drug distributed nationwide in the USA, Puerto Rico, and the US Virgin Islands.
The recall was issued due to lack of assurance of sterility. Multi-dose injectables must maintain sterility to prevent contamination and potential infection in patients receiving the medication.
Patients and healthcare providers should discontinue use of affected vials immediately. Contact your healthcare provider or Olympia Compounding Pharmacy if you have received this product.
The recalled product
- Product
- Zinc Chloride (0.5 mg/mL), Multi-Dose 30 mL vial, Rx Only, Olympia Pharmaceuticals, 6700 Conroy Rd., Ste. 155 Orlando, FL 32835, NDC 73198-0071-30
- Manufacturer
- Olympia Compounding Pharmacy dba Olympia Pharmacy
- Category
- Drug — Injectable
- Hazard
- lack-of-sterility
- contamination
Is your product affected?
Check your packaging against the codes below. If any of them match, the product is part of this recall.
Lot numbers (1)
- Lot: K24024 BUD: 5/24/2022
Distribution
Distributed nationwide across the United States.
Related recalls
Same category
- CriticalWarfarin Tablets Recalled After Mix-Up Between 2.5 mg and 5 mg Strengths
FDA (Drugs) · 2026-07-21
- ModerateFDA Recalls Pred Mild Ophthalmic Suspension Due to Failed Stability Specifications
FDA (Drugs) · 2026-06-03
- ModerateNicotine Transdermal System Patches Recalled for Oxidative Impurity Specification Failure
FDA (Drugs) · 2026-06-03
- LowPrimidone Tablets Recalled Due to Cross-Contamination with Acemetacin
FDA (Drugs) · 2026-05-27
- HighLiraglutide Injection Recalled Due to Particulate Matter in Cartridges
FDA (Drugs) · 2026-05-27